カテゴリ： MarketLine, イギリス, 企業調査

Hikma Pharmaceuticals PLC：企業の戦略・SWOT・財務情報

◆英語タイトル：Hikma Pharmaceuticals PLC - Strategy, SWOT and Corporate Finance Report
◆商品コード：DATA904C1941
◆発行会社（調査会社）：MarketLine
◆発行日：2018年7月
◆ページ数：49
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：イギリス
◆産業分野：製薬・医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Hikma Pharmaceuticals PLC – Strategy, SWOT and Corporate Finance Report
Summary

Hikma Pharmaceuticals PLC – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Hikma Pharmaceuticals (Hikma or ‘the company’) is engaged in the development, manufacturing and marketing of generic and in-licensed pharmaceutical products. The company offers diversified product portfolio and pipeline across a broad range of therapeutic categories including: anti-infectives, cardiovascular, central nervous system, diabetes, oncology, pain management and respiratory. It offers its products in various dosage forms including tablets, capsules, solutions and suspensions. The company markets its products under brands such as Amoclan, Blopress, Suprax , Omnicef, Prograf, Suprax and Cresemba. Hikma sells its products through leading wholesalers, pharmacy chains, governments and hospital purchasing organisations. The company primarily operates in the Middle East and North Africa (MENA), the US and Europe. Hikma is headquartered in London, the UK.

Scope

- Detailed information on Hikma Pharmaceuticals PLC required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Hikma Pharmaceuticals PLC in the form of a SWOT analysis
- An in-depth view of the business model of Hikma Pharmaceuticals PLC including a breakdown and examination of key business segments
- Intelligence on Hikma Pharmaceuticals PLC’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Hikma Pharmaceuticals PLC, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Hikma Pharmaceuticals PLC and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Hikma Pharmaceuticals PLC as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Hikma Pharmaceuticals PLC’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
Hikma Pharmaceuticals PLC: Company Overview 9
Hikma Pharmaceuticals PLC: Overview and Key Facts 9
Hikma Pharmaceuticals PLC: Overview 9
Hikma Pharmaceuticals PLC: Key Facts 9
Hikma Pharmaceuticals PLC: Key Employees 11
Hikma Pharmaceuticals PLC: Key Employee Biographies 13
Hikma Pharmaceuticals PLC: Major Products and Services 16
Hikma Pharmaceuticals PLC: Company History 17
Hikma Pharmaceuticals PLC: Management Statement 21
Hikma Pharmaceuticals PLC: Locations and Subsidiaries 24
Hikma Pharmaceuticals PLC: Key Competitors 25
Hikma Pharmaceuticals PLC: Company Analysis 26
Hikma Pharmaceuticals PLC: Business Description 26
Hikma Pharmaceuticals PLC: SWOT Analysis 28
Hikma Pharmaceuticals PLC: SWOT Overview 28
Hikma Pharmaceuticals PLC: Strengths 28
Hikma Pharmaceuticals PLC: Weaknesses 29
Hikma Pharmaceuticals PLC: Opportunities 29
Hikma Pharmaceuticals PLC: Threats 30
Hikma Pharmaceuticals PLC: Corporate Financial Deals Activity 31
Hikma Pharmaceuticals PLC: Financial Deals Overview 31
Hikma Pharmaceuticals PLC: Targets and Partners 33
Hikma Pharmaceuticals PLC: Top Deals 2014 – 2018YTD* 34
Hikma Pharmaceuticals PLC: Advisors 35
Hikma Pharmaceuticals PLC: Top Legal Advisors 35
Hikma Pharmaceuticals PLC: Top Financial Advisors 35
Hikma Pharmaceuticals PLC: Mergers and Acquisitions 36
Hikma Pharmaceuticals PLC: Partnership 37
Hikma Pharmaceuticals PLC: Divestments 38
Hikma Pharmaceuticals PLC: Recent Developments 39
Hikma Pharmaceuticals PLC: News and Events Summary 39
Hikma Pharmaceuticals PLC: Business Expansion 42
Hikma Pharmaceuticals PLC: Corporate Governance 42
Hikma Pharmaceuticals PLC: Financial Deals 44
Hikma Pharmaceuticals PLC: Financial Performance 44
Hikma Pharmaceuticals PLC: Research & Development 45
Hikma Pharmaceuticals PLC: Strategy and Operations 45
Appendix 47
Contact Us 47
Methodology 47
About MarketLine 48

List of Tables
Table 1: Hikma Pharmaceuticals PLC: Key Facts
Table 2: Hikma Pharmaceuticals PLC: Key Employees
Table 3: Hikma Pharmaceuticals PLC: Locations and Subsidiaries
Table 4: Hikma Pharmaceuticals PLC: Key Competitors
Table 5: Hikma Pharmaceuticals PLC: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Hikma Pharmaceuticals PLC: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 7: Hikma Pharmaceuticals PLC: M&A Average Deal Size - Value (US$m)
Table 8: Hikma Pharmaceuticals PLC: Targets and Partners
Table 9: Hikma Pharmaceuticals PLC: Top Deals 2014 - 2018YTD*
Table 10: Hikma Pharmaceuticals PLC: Legal Advisor Ranking by Value (US$m)
Table 11: Hikma Pharmaceuticals PLC: Financial Advisor Ranking by Value (US$m)
Table 12: Hikma Pharmaceuticals PLC: M&A Volume and Value Trend (2014 - YTD*2018)
Table 13: Hikma Pharmaceuticals PLC: M&A Activity by Geography (2014 - YTD*2018)
Table 14: Hikma Pharmaceuticals PLC: Partnership Volume and Value Trend (2014 - YTD*2018)
Table 15: Hikma Pharmaceuticals PLC: Partnership Trend by Deal Type (2014 - YTD*2018)
Table 16: Hikma Pharmaceuticals PLC: Divestments Volume and Value Trend (2014 - YTD*2018)
Table 17: Hikma Pharmaceuticals PLC: News and Events Summary
Table 18: Hikma Pharmaceuticals PLC: Business Expansion
Table 19: Hikma Pharmaceuticals PLC: Corporate Governance
Table 20: Hikma Pharmaceuticals PLC: Financial Deals
Table 21: Hikma Pharmaceuticals PLC: Financial Performance
Table 22: Hikma Pharmaceuticals PLC: Research & Development
Table 23: Hikma Pharmaceuticals PLC: Strategy and Operations

List of Figures
Figure 1: Hikma Pharmaceuticals PLC: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Hikma Pharmaceuticals PLC: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 3: Hikma Pharmaceuticals PLC: M&A Average Deal Size - Value (US$m)
Figure 4: Hikma Pharmaceuticals PLC: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 5: Hikma Pharmaceuticals PLC: M&A Activity by Geography (2014 - YTD*2018)
Figure 6: Hikma Pharmaceuticals PLC: Partnership Volume and Value Trend (2014 - YTD*2018)
Figure 7: Hikma Pharmaceuticals PLC: Partnership Trend by Deal Type (2014 - YTD*2018)
Figure 8: Hikma Pharmaceuticals PLC: Divestments Volume and Value Trend (2014 - YTD*2018)

★海外企業調査レポート[Hikma Pharmaceuticals PLC：企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Endo International Plc (ENDP)：企業の財務・戦略的SWOT分析
    Endo International Plc (ENDP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • BP Plc Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    BP Plc Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary BP Plc (BP) is an integrated oil and gas company. Its upstream activities include exploration, development and production of oil and natural gas, field development and production; and midstream operations inc …
  • ARC Resources Ltd Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    ARC Resources Ltd Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary ARC Resources Ltd (ARC) is an energy company, which carries out exploration, development and production of conventional crude oil and natural gas reserves. Its produces light and medium crude oil, …
  • Aequus Pharmaceuticals Inc (AQS)：医療機器：M&Aディール及び事業提携情報
    Summary Aequus Pharmaceuticals Inc (Aequus Pharmaceuticals) is a drug discovery and development company that develops differentiated drugs. The company’s pipeline products include AQS301, AQS302 and AQS303. Its commercial pipeline comprises ophthalmology products and transplant products. Aequus Phar …
  • Oncolytics Biotech Inc (ONC)：医療機器：M&Aディール及び事業提携情報
    Summary Oncolytics Biotech Inc (Oncolytics) is a development stage biopharmaceutical company which focuses on the discovery and development of oncolytic viruses for the treatment of cancer. The company’s lead product, Reolysin, a formulation of the human reovirus, is indicated for the treatment of l …
  • Banco Daycoval SA：企業の戦略・SWOT・財務情報
    Banco Daycoval SA - Strategy, SWOT and Corporate Finance Report Summary Banco Daycoval SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • bitop AG-医療機器分野：企業M&A・提携分析
    Summary Bitop AG (bitop) is a developer, manufacturer and marketer of cosmetic ingredients. The company offers extremolytes, medical devices, cosmetic ingredients and bio-stabilizer products. It offers medical devices for dermatology, allergy, cough and cold; airway diseases and dry epithelia applic …
  • Grupo Aeroportuario del Sureste SAB de CV：企業の戦略・SWOT・財務情報
    Grupo Aeroportuario del Sureste SAB de CV - Strategy, SWOT and Corporate Finance Report Summary Grupo Aeroportuario del Sureste SAB de CV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SW …
  • Pakistan Petroleum Ltd Oil & Gas Exploration and Production Operations and Cost Analysis – 2017
    Pakistan Petroleum Ltd Oil & Gas Exploration and Production Operations and Cost Analysis - 2017 Summary Pakistan Petroleum Ltd (PPL) is an upstream oil and gas company. It explores, develops and produces crude oil and natural gas resources. The company operates producing fields at Sui, Kandhkot, Adh …
  • PT Bayan Resources Tbk.：企業の戦略・SWOT・財務情報
    PT Bayan Resources Tbk. - Strategy, SWOT and Corporate Finance Report Summary PT Bayan Resources Tbk. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Genera Biosystems Ltd (GBI)-製薬・医療分野：企業M&A・提携分析
    Summary Genera Biosystems Ltd (GBL) is a developer and commercializer of multiplexed molecular diagnostic testing products. The company offers RTIplex and PapType molecular diagnostic test. Its RTIplex is a multiplexed and automated PCR based test for detection of viral and bacterial respiratory pat …
  • Toppan Printing Co Ltd：企業のM&A・事業提携・投資動向
    Toppan Printing Co Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Toppan Printing Co Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • Lundin Gold Inc：戦略・SWOT・企業財務分析
    Lundin Gold Inc - Strategy, SWOT and Corporate Finance Report Summary Lundin Gold Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Smithfield Foods Inc：戦略・SWOT・企業財務分析
    Smithfield Foods Inc - Strategy, SWOT and Corporate Finance Report Summary Smithfield Foods Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Bank Sepah：企業の戦略・SWOT・財務情報
    Bank Sepah - Strategy, SWOT and Corporate Finance Report Summary Bank Sepah - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Bank of Singapore Ltd.：企業の戦略・SWOT・財務情報
    Bank of Singapore Ltd. - Strategy, SWOT and Corporate Finance Report Summary Bank of Singapore Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Companhia Riograndense de Mineracao：企業の戦略・SWOT・財務情報
    Companhia Riograndense de Mineracao - Strategy, SWOT and Corporate Finance Report Summary Companhia Riograndense de Mineracao - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Stora Enso Oyj：企業の戦略・SWOT・財務分析
    Stora Enso Oyj - Strategy, SWOT and Corporate Finance Report Summary Stora Enso Oyj - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • The Siam Cement Public Co Ltd：企業の戦略・SWOT・財務情報
    The Siam Cement Public Co Ltd - Strategy, SWOT and Corporate Finance Report Summary The Siam Cement Public Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Trellis Bioscience Inc-製薬・医療分野：企業M&A・提携分析
    Summary Trellis Bioscience Inc (Trellis) is a healthcare services provider that offers therapies. The company discovers and develops human antibody therapeutics for the treatment of infectious diseases and cancer indications. It provides technology to defeat the deficiencies of current screening met …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆